A Phase I Trial of Samarium-153-Lexidronam Complex for Treatment of Clinically Nonmetastatic High-Risk Prostate Cancer: First Report of a Completed Study

Richard K. Valicenti,Edouard Trabulsi,Charles Intenzo,Jorosali Lavarino,Yihuan Xu,Inna Chervoneva

International Journal of Radiation Oncology*Biology*Physics（2011）

引用 11|浏览9

暂无评分

摘要

Conclusions Our trial demonstrates that 2 mCi/kg 153 Sm -EDTMP with HT and RT was safe and feasible in men with high-risk M0 prostate cancer. A Phase II study to test this treatment is currently underway by the Radiation Therapy Oncology Group.

查看译文

关键词

Prostate cancer,Hormonal therapy,Radiation therapy,Samarium-153

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要